In some individuals with persistent, debilitating fatigue following SRAS-CoV-2 infection, documented damage of vital organs may be a sufficient explanation for their fatigue
Who May Benefit from Lip Lightening
In the United States, the FDA Biomarker Qualification Program was designed to formalize the use of biomarkers in therapeutic development, but progress has been slow
Maruyama T, Higuchi T, Yamazaki T, Okawa E, Ando H, Oikawa O, et al
Antibodies The following rabbit polyclonal antibodies were used: anti-GSTM2 (#ab125,102, Abcam, Cambridge, UK, 1:1000), anti-GSTM2 (#A13,496, ABclonal, Wuhan, China, 1:2000), anti-GAPDH (#CSB-PA00025A0Rb Flarebio Biotech LLC, College Park, MD, USA, 1:1000), anti-CIDEC (#D222114, Sangon Biotech, Shanghai, China, 1:1000), anti-CIDEC (#12287-1-AP, Proteintech, Rocky Hill, NJ, USA, 1:1000), anti-ADRP/perilipin2 (#15294-1-AP, Proteintech), anti-DGAT2 (#bs-12,998R, BIOSS, Beijing, China), anti-DGAT2 (#A13,891, ABclonal, Wuhan, China, 1:2000), anti-GPAT4 (#bs-15,587R, BIOSS), anti-SREBP1 (#14,088-1-AP, Proteintech), and anti-PCYT1A (#bs-11306R, BIOSS), anti-PCYT1A (#A5935, ABclonal, Wuhan, China, 1:1000)